Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
Rhizen Pharmaceuticals SA
Scientific Title
A Phase I/Ib, Study to Evaluate Safety and Efficacy of RP4010, in Patients With Relapsed or Refractory Lymphomas